View in EDS HTML Full Text PDF Full Text

Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial.

Saved in:
Bibliographic Details
Title: Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial.
Authors: Zeyen, Thomas1 (AUTHOR), Potthoff, Anna-Laura2 (AUTHOR), Nemeth, Robert3 (AUTHOR), Heiland, Dieter H.4,5 (AUTHOR), Burger, Michael C.6 (AUTHOR), Steinbach, Joachim P.6 (AUTHOR), Hau, Peter7 (AUTHOR), Tabatabai, Ghazaleh8 (AUTHOR), Glas, Martin9 (AUTHOR), Schlegel, Uwe10 (AUTHOR), Grauer, Oliver11 (AUTHOR), Krex, Dietmar12 (AUTHOR), Schnell, Oliver4,5 (AUTHOR), Goldbrunner, Roland13 (AUTHOR), Sabel, Michael14 (AUTHOR), Thon, Niklas15 (AUTHOR), Delev, Daniel16 (AUTHOR), Clusmann, Hans16 (AUTHOR), Seidel, Clemens17 (AUTHOR), Güresir, Erdem2 (AUTHOR)
Source: Trials. 5/17/2022, Vol. 23 Issue 1, p1-16. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17456215
DOI:10.1186/s13063-021-05977-0